Alan Martin

9PUBLICATIONS
29CO-AUTHORS
Cross-sectional analysisMedical biotechnology diagnostics (incl. biosensors)Toxicology (incl. clinical toxicology)Comparative language studiesSemi- and unsupervised learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 12, 2025
Economic Analysis of New Single-Inhaler Triple Therapies in Patients with COPD in the UK.

Rui Cai, Alan A Martin, Yuchen Ge

|Jun 24, 2025
Cost-Effectiveness of Single-Inhaler Versus Multiple-Inhaler Triple Therapy in COPD: A German Healthcare Perspective.

Kai-Michael Beeh, Jing Claussen, Dhvani Shah

|Aug 28, 2023
Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) versus Tiotropium Monotherapy in Patients with Symptomatic Moderate-to-Very Severe COPD in the UK.

Robyn Kendall, Alan A Martin, Dhvani Shah

|Dec 23, 2022
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial.

Victoria Federico Paly, Laura Amanda Vallejo-Aparicio, Alan Martin

|Nov 01, 2022
Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial.

David M G Halpin, Robyn Kendall, Soham Shukla

|Aug 02, 2022
Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial.

Andrea Gabrio, Necdet B Gunsoy, Gianluca Baio

Pageof 2